Summary What is already known about this topic?Annually,only the incidence and mortality for Acquired Immune Deficiency Syndrome(AIDS)patients are officially disclosed.What is added by this report?For the first time,i...Summary What is already known about this topic?Annually,only the incidence and mortality for Acquired Immune Deficiency Syndrome(AIDS)patients are officially disclosed.What is added by this report?For the first time,information detailing the reported rate,mortality rate,and prevalence rate trends of HIV,AIDS,and HIV/AIDS in China’s entire population over the past two decades has been provided.What are the implications for public health practice?Our research overcomes the longstanding limitation of HIV/AIDS analysis as the sole denominator.Rather,it incorporates a comprehensive examination of the overall population,utilizing indicators and analytic methods from chronic disease analyses.展开更多
What is already known about this topic?The advent of antiretroviral therapy(ART)has markedly decreased mortality rates among patients infected with human immunodeficiency virus(HIV).Globally,there has been a 43%reduct...What is already known about this topic?The advent of antiretroviral therapy(ART)has markedly decreased mortality rates among patients infected with human immunodeficiency virus(HIV).Globally,there has been a 43%reduction in acquired immunodeficiency syndrome(AIDS)-related deaths from 2010 to 2022.Additionally,prior research indicates that the initiation of ART at an early stage within China has substantially lowered mortality rates.What is added by this report?Over the previous decade,following the implementation of China’s universal ART access strategy,the patterns of mortality causes among HIVinfected individuals across the country have undergone significant alterations.In 2022,the all-cause mortality rate among this population was reported at 2.7%,with the non-AIDS-related mortality rate at 1.8%.However,it is important to consider that the accuracy of death reporting could contribute to potential misclassification of the underlying causes of death.What are the implications for public health practice?Efforts to enhance health outcomes should persist in emphasizing the advancement of ART strategies,with a particular focus on mitigating non-AIDS-related mortality in the future.展开更多
基金National Key Contact Areas for Disability Prevention Expert Technical Service Project(NO.2023P113QG012)National Key Research and Development Program(SQ2022YFC3600291).
文摘Summary What is already known about this topic?Annually,only the incidence and mortality for Acquired Immune Deficiency Syndrome(AIDS)patients are officially disclosed.What is added by this report?For the first time,information detailing the reported rate,mortality rate,and prevalence rate trends of HIV,AIDS,and HIV/AIDS in China’s entire population over the past two decades has been provided.What are the implications for public health practice?Our research overcomes the longstanding limitation of HIV/AIDS analysis as the sole denominator.Rather,it incorporates a comprehensive examination of the overall population,utilizing indicators and analytic methods from chronic disease analyses.
文摘What is already known about this topic?The advent of antiretroviral therapy(ART)has markedly decreased mortality rates among patients infected with human immunodeficiency virus(HIV).Globally,there has been a 43%reduction in acquired immunodeficiency syndrome(AIDS)-related deaths from 2010 to 2022.Additionally,prior research indicates that the initiation of ART at an early stage within China has substantially lowered mortality rates.What is added by this report?Over the previous decade,following the implementation of China’s universal ART access strategy,the patterns of mortality causes among HIVinfected individuals across the country have undergone significant alterations.In 2022,the all-cause mortality rate among this population was reported at 2.7%,with the non-AIDS-related mortality rate at 1.8%.However,it is important to consider that the accuracy of death reporting could contribute to potential misclassification of the underlying causes of death.What are the implications for public health practice?Efforts to enhance health outcomes should persist in emphasizing the advancement of ART strategies,with a particular focus on mitigating non-AIDS-related mortality in the future.
